Skip to main content
Glama

get_dataset_info

Read-onlyIdempotent

Get FineRx dataset coverage, freshness, and the attribution/disclaimer terms.

Returns dataset counts (drugs, products, prices, chains, savings programs, pharmacy locations), the latest observation date, and the terms every consumer must honor (attribution + disclaimer).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault

No arguments

Output Schema

TableJSON Schema
NameRequiredDescriptionDefault

No arguments

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false, which fully cover the safety profile. The description adds context about what the call returns (counts, freshness, terms) without contradicting any annotation. It does not disclose rate limits or caching, but for a simple metadata endpoint the annotations plus output summary are sufficient.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is two sentences: a terse purpose line followed by a structured list of return fields. Every sentence carries information, with the purpose front-loaded and the output details organized into scannable groups. No filler or redundancy.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With zero parameters, strong read-only annotations, and an output schema present, the description fully captures what an agent needs to know: what the tool returns and why it exists. No critical operational detail such as prerequisites, side effects, or authentication is missing for this metadata endpoint.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema has zero parameters, so there are no parameter semantics to document. The baseline of 4 applies, and the description appropriately focuses on the output rather than inputs, matching the empty schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with 'Get FineRx dataset coverage, freshness, and the attribution/disclaimer terms,' naming a specific verb and resource. It then enumerates exact return categories (counts, observation date, terms), making it clearly distinct from the sibling drug/price/location tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description does not explicitly name sibling tools or exclusions, but it establishes a unique context: dataset-level metadata about coverage and legal terms. With zero parameters and no overlapping sibling operation, the intended use case is readily apparent. An explicit 'use when you need dataset-level facts' clause would make it a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources